跳至主要内容
临床试验/ACTRN12614000272695
ACTRN12614000272695已完成2 期

eurostimulation versus Artificial Tears to Treat Post-LASIK Dry Eye in Adults Measured via Two Dry Eye Questionnaires

Oculeve, Inc.0 个研究点目标入组 60 人开始时间: 2014年3月14日最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
Oculeve, Inc.
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
21 Years 至 o limit(—)
性别
All

入选标准

  • Patients meeting all criteria for appropriateness of LASIK surgery instituted by the treating centre with an established date for bilateral primary LASIK surgery
  • Willing to sign the informed consent and deemed capable of complying with the requirements of the study protocol
  • Normal lid anatomy, blinking function and closure
  • Corrected visual acuity of 20/25 (Snellen equivalent) or better in each eye

排除标准

  • Cardiac demand pacemaker, implanted defibrillator, or other active implanted metallic or electronic device
  • Diagnosed epilepsy with seizures within the past five years
  • Coagulation disorders such as haemophilia and thrombocytopenia
  • Active or uncontrolled severe systemic allergy, chronic seasonal allergies, rhinitis or sinusitis requiring treatment or active/untreated nasal infection at the time of the baseline examination
  • Punctal plugs
  • Contact lens wear during the study
  • Lacrimal, nasal or sinus neoplasia, significant trauma, or invasive surgery
  • Chronic or recurrent epistaxis, history of cocaine abuse, or Wegener’s granulomatosis
  • Participation in any clinical trial with a new active substance or a new device during the past three months
  • Women who are pregnant, planning a pregnancy or nursing at study entry

研究者

发起方
Oculeve, Inc.

相似试验